MSF’s Panel Discussion: Bridging the Gap: Securing Access to Essential TB Medicines in the EU and EEA

17 October 2025

Brussels, 14 October 2025: Although tuberculosis (TB) is both preventable and curable, people with TB across Europe continue to face unnecessary suffering due to limited access to effective prevention and treatment medicines. While low- and middle-income countries with high burdens of TB have taken measures to improve access to new and existing medicines and other medical tools, inadequate access to new and existing medicines and slow adoption of updated treatment guidance by the World Health Organization remain a major challenge in many countries in the European Union (EU) and European Economic Area (EEA).

Drawing on findings from MSF’s recent Technical Brief, MSF hosted a panel discussion to highlight the key barriers to access and explore the important role that different stakeholders can play at both national and regional levels to improve the availability and affordability of TB medicines in the EU and EEA.

The recording of the panel discussion is now available online and can be accessed here.

Source: Médecins Sans Frontières (MSF)